Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.28
+0.41 (6.98%)
At close: Dec 5, 2025, 4:00 PM EST
6.16
-0.12 (-1.91%)
After-hours: Dec 5, 2025, 5:01 PM EST
Eupraxia Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -29.37 | -25.5 | -28.22 | -18.49 | -18.93 | -3.14 | |
| Depreciation & Amortization | 0.22 | 0.17 | 0.16 | 0.15 | 0.09 | 0.09 | |
| Loss (Gain) From Sale of Assets | -0.01 | -0.02 | 0 | 0.01 | - | 0.1 | |
| Stock-Based Compensation | 4.08 | 3.22 | 1.41 | 1.43 | 2.71 | 0.18 | |
| Other Operating Activities | 0.19 | -1.1 | 0.55 | 0.99 | 4.72 | 1.2 | |
| Change in Accounts Receivable | -0.09 | -0.1 | -0.1 | 0.23 | 0.15 | 0.57 | |
| Change in Accounts Payable | 1.47 | -0.71 | 0.58 | 1.32 | -0.5 | 0.67 | |
| Change in Other Net Operating Assets | -1.3 | -5.95 | 4.88 | -0.04 | 0.05 | 0 | |
| Operating Cash Flow | -24.8 | -29.99 | -20.75 | -14.4 | -11.72 | -0.32 | |
| Capital Expenditures | -0.44 | -0.1 | -0.07 | -0.24 | -0.34 | - | |
| Sale of Property, Plant & Equipment | 0 | 0.03 | - | 0 | - | 0.06 | |
| Investment in Securities | - | - | - | 10.07 | -7.11 | - | |
| Other Investing Activities | - | - | - | - | -3.97 | -0.04 | |
| Investing Cash Flow | -0.44 | -0.08 | -0.07 | 9.83 | -11.42 | 0.02 | |
| Short-Term Debt Issued | - | - | - | - | 0.08 | 0.56 | |
| Long-Term Debt Issued | - | - | - | - | 10.08 | - | |
| Total Debt Issued | - | - | - | - | 10.16 | 0.56 | |
| Long-Term Debt Repaid | - | -9.14 | -0.08 | -0.14 | -0.46 | -0.86 | |
| Net Debt Issued (Repaid) | - | -9.14 | -0.08 | -0.14 | 9.69 | -0.31 | |
| Issuance of Common Stock | 106.3 | 54.92 | 21.16 | 10.94 | 29.9 | - | |
| Other Financing Activities | - | - | - | - | - | -0.19 | |
| Financing Cash Flow | 106.3 | 45.78 | 21.08 | 10.8 | 39.59 | -0.49 | |
| Foreign Exchange Rate Adjustments | -0.76 | -1.96 | 0.82 | -0.51 | -0.06 | -0 | |
| Net Cash Flow | 80.3 | 13.76 | 1.08 | 5.73 | 16.39 | -0.79 | |
| Free Cash Flow | -25.24 | -30.1 | -20.82 | -14.63 | -12.06 | -0.32 | |
| Free Cash Flow Per Share | -0.70 | -0.89 | -0.86 | -0.76 | -0.97 | -0.05 | |
| Cash Interest Paid | 0 | 0.39 | 0.6 | 0.33 | 0.46 | 0.09 | |
| Levered Free Cash Flow | -14.73 | -20.95 | -10.78 | -8.72 | -12.98 | -0.59 | |
| Unlevered Free Cash Flow | -14.5 | -20.35 | -10.05 | -8.11 | -12.37 | 0.34 | |
| Change in Working Capital | 0.09 | -6.76 | 5.35 | 1.51 | -0.3 | 1.24 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.